References
- Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 2001; 13: 560–567
- Cheon KA, Ryu YH, Kim JW, Cho DY. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 2005; 15: 95–101
- Duvernoy, HM, 1999. The human brain. Surface, three-dimensional sectional anatomy and MRI: Surface, three-dimensional sectional anatomy with MRI and blood supply. Vienna: Springer.
- Ellis CM, Lemmens G, Williams SC, et al. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology 1997; 49: 438–444
- Giros B, Caron MG. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993; 14: 43–49
- Heinz A, Goldman D, Jones DW, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000; 22: 133–139
- Jacobsen LK, Staley JK, Zoghbi SS, et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000; 157: 1700–1703
- Krause J, Dresel SH, Krause KH, La Fougere C, Zill P, Ackenheil M. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry 2006; 7: 152–157
- Marenco S, Steele SU, Egan MF, et al. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. Am J Psychiatry 2006; 163: 740–742
- Martinez D, Gelernter J, Abi-Dargham A, et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001; 24: 553–560
- Mignone, F, Gissi, C, Liuni, S, Pesole, G. 2002. Untranslated regions of mRNAs. Genome Biol 3, REVIEWS0004
- Mitchell RJ, Howlett S, Earl L, et al. Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations. Hum Biol 2000; 72: 295–304
- Saxena S, Bota RG, Brody AL. Brain-behavior relationship in obsessive-compulsive disorder. Sem Clin Neuropsychiatry 2001; 6: 82–101
- Scherk H, Gruber O, Backens M, et al. MR-spectroscopic alterations in subcortical regions in patients with bipolar I disorder. Schizophr Res 2006; 66(Suppl S)66
- Strakowski SM, DelBEllo MP, Adler CM. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychol 2005; 10: 105–116
- Talairach, P., Tournoux. 1998. Coplanar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers.
- Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104–1106
- Wittchen, HU, Zaudig, M, Fydrich, T. 1997. Strukturiertes klinisches Interview für DSM-IV Achse I und II. Hogrefe, Göttingen